Prof Amminger is a Psychiatrist, Head of Neuroprotective Biotherapies Research at Orygen, and Professor of Neurobiology and Neuroprotection in Emerging Mental Disorders at the Centre of Youth Mental Health, University of Melbourne. He pioneered the use of omega-3 fatty acids for preventing psychosis in young people at high risk, providing an avenue for early intervention. He is engaged in clinical trials research testing agents with favourable risk-benefit ratio for treatment and preventive use in young people with mental health problems.
Professor Paul Amminger
9 November 2021Related Posts

CREDIT Researchers feature in Magda’s Big National Health Check
Professor Pat McGorry (Orygen) and Alfred Deakin Professor Felice Jacka
Continue Reading
Meet Alfred Deakin Professor Felice Jacka OAM
CREDIT CRE researcher, Felice Jacka OAM, has been bestowed the
Continue Reading
Recent publication by CREDIT CRE researchers
Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis
Continue Reading
Study of attachment and bipolar disorder by CREDIT researchers
Bipolar disorder is a potentially debilitating and lifelong mental health
Continue Reading
About Us
Find us
CREDIT CRE Deakin University, 221 Burwood Highway, Burwood ,VIC, 3125Get in touch
Email us
impact@deakin.edu.au
Call us
(+613) 5227 3762